Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants.
Cherian
M P
MP
AbdulJabbar
M
M
D000287:Administration, Topical; D000311:Adrenal Glands / Q000187:drug effects*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002990:Clobetasol / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D003480:Cushing Syndrome / Q000139:chemically induced*; D005938:Glucocorticoids; D006801:Humans; D007223:Infant; D008297:Male; D012869:Skin Absorption
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D002990:Clobetasol